New Delhi: Drug firm Unichem Laboratories recently said it has received a tentative nod from the US health regulator for generic Tadalafil tablets used for the treatment of erectile dysfunction.
The company has received the tentative approval from the United States Food and Drug Administration for its Tadalafil tablets in the strengths of 2.5 mg, 5 mg, 10 mg and 20 mg, Unichem Laboratories said in a filing to the BSE.
The tablets are used for the treatment of erectile dysfunction, signs and symptoms of benign prostatic hyperplasia and ED/BPH, Unichem Laboratories added.
The product is a generic version of Eli Lilly’s Cialis tablets in the same strengths, it added.
Unichem Laboratories is a pharmaceutical company headquartered in Mumbai.
Latest posts by MD Team (see all)
- Recordati to seek Canadian approval for kidney disease drug Cystagon - April 17, 2019
- Wockhardt gets zero USFDA observations for Bioequivalence centre - April 16, 2019
- Amgen sets over Rs 15 lakh yearly price for new bone drug Evenity - April 16, 2019